News

JDRF Awards $9 Million US for Phase 3 Type 1 Diabetes Kidney Disease Clinical Trial, Joins The Kidney Foundation of Canada in Driving Research to Treat Kidney Disease

Planet 13 Enters into Definitive Agreement to Sell Its Medical Marijuana Treatment Center License in Florida in Connection with the Previously Announced Definitive Agreement to Acquire Vidacann

AIM ImmunoTech Announces that the First Subject is Enrolled in the Phase 1b/2 Study Evaluating Ampligen® in Combination with AstraZeneca’s Imfinzi® for the Treatment of Late-Stage Pancreatic Cancer

error: Content is protected !!